About
Steven Breazzano is currently Director of TA Strategy (CRM) at Novartis, having previously served as a Principal at Deep Track Capital, LP in Greenwich, Connecticut, until 2025. At Deep Track Capital, he was responsible for investment strategy with a primary focus on healthcare and life sciences sectors, contributing to the firm's portfolio development and deal execution within these specialized industries.
Before joining Deep Track Capital, Breazzano was a Senior Analyst at Casdin Capital from 2018 to 2021, where he developed deeper sector expertise in biotechnology and medical technology investments. His roles have centered on sourcing and evaluating growth opportunities in innovative health companies, leveraging a robust analytical foundation and sector-specific insight.
Breazzano’s background demonstrates significant expertise in portfolio construction, equity research, and strategic investment in cutting-edge healthcare solutions. He is recognized for advancing investment strategies that support technology-driven transformation across life sciences and healthcare services.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Deep Track Capital | Principal | Apr 2021 to Present | Deep Track Capital is a Greenwich, Connecticut-based investment firm focused exclusively on the life sciences industry. We seek to invest in long term partnerships with management teams leading innova... |
Education
Brandeis University
Columbia University
Scripps Research
Others at Deep Track Capital, LP (1)
| Name | Role | Location |
|---|---|---|
B Brett Erkman | Managing Director | New York, NY , United States |